Elsevier Launches New Online ARRA Resource Center and Clinical Decision Support Blog

Exclusive updates from Elsevier’s top thought leaders provide insight on healthcare reform and ARRA momentum

Philadelphia, PA, 30 November 2009 – Elsevier, a world leader in healthcare publications/information as well as web-based and electronic health record (EHR) integrated solutions, today announced a new online resource center for American Recovery and Reinvestment Act (ARRA) updates and initiatives. Accessible via Elsevier’s ClinicalDecisionSupport.com site, or by going to www.clinicaldecisionsupport.com/ARRA, the resource center and accompanying blog provide users with updates on ARRA progress and actions, as well as insightful commentary on emerging trends and issues from top Elsevier executives Jonathan Teich, M.D., Ph.D.; Michelle Troseth, RN, MSN, DPNAP; and Swati Abbott, MS.

Meaningful clinical decision support (CDS) is a key tenet of healthcare reform and ARRA goals for quality improvement. Designed to assist physicians and other care providers with decisions at the point-of-care, CDS systems assimilate data on a variety of conditions and diagnoses and can flag potential issues, such as unsafe medication interactions, that may end up being harmful to patients as well as costly to the entire healthcare system.

“Elsevier’s CDS blog and ARRA portal are designed to be a solution to the challenge of keeping current with national quality initiatives, meaningful use updates, and other significant new policies and programs that affect providers, payers, and patients,” said Dr. Teich, Elsevier’s Chief Medical Informatics Officer. “The blog will be a way to facilitate discussions on many topics relevant to the market today, including the role of CDS in the national healthcare environment.”

Elsevier has been a leader in the CDS industry for many years. Elsevier’s Consult Suite (i.e., First Consult, MD Consult, Nursing Consult) and Gold Standard/Elsevier drug information products make knowledge accessible via the EHR so physicians, nurses and pharmacists can make better clinical decisions within the workflow and at the point of care. Elsevier’s CPM Resource Center (CPMRC) provides a well-tested framework including integrated evidence-based interdisciplinary content and transformational services at the point of care. CPMRC has an active international healthcare consortium that co-creates clinician- and patient-focused CDS tools and resources for healthcare transformation. In addition, through MEDai, Elsevier delivers a patient-specific, real-time clinical surveillance solution that is driven by predictive analytics to identify a patient’s risk for re-admission and hospital-acquired infection while the patient is still in the hospital. The MEDai Pinpoint Suite, including the newly launched Pinpoint Review®, offers clinicians greater insight at the point of care, resulting in a higher quality of care for both patient and provider.

Elsevier’s blog is launching with introductory postings from Michelle Troseth, Executive Vice President and Chief Professional Practice Officer, CPMRC, and Swati Abbott, President of MEDai. Troseth’s first blog post discusses the “meaningful use” matrix and addresses considerations for healthcare leaders and organizations today, while Abbott’s entry highlights common ailments and some possible solutions for our healthcare system, especially with regard to technology. Readers can expect regular updates to the blog as well as guest blog entries from leading industry executives.

“Elsevier understands the significance of ARRA and the demands and opportunities it presents for hospitals and other care-providing facilities,” continued Teich. “We see ourselves as a partner to healthcare executives and point of care clinicians who seek expert commentary and feedback on the changing healthcare landscape.”

About Elsevier
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Research Intelligence and ClinicalKey— and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries. www.elsevier.com

Media Contact:
Tom Reller
Elsevier
+1 215 239 3508
t.reller@elsevier.com